NCT03032263

Brief Summary

Nasal intubation is frequently used for dental procedures to promote an unimpeded view of the oral cavity. A nasal RAE endotracheal tube is longer than a standard oral endotracheal tube (ETT) and it is shaped so that end of the tube which attaches to the ventilator exits upward toward the forehead. This unique shape ensures that the tube will not interfere with surgical exposure of the oral cavity and mandible. The nasal RAE ETT can be placed in the trachea using either direct laryngoscopy (DL) or video laryngoscopy (C-Mac) . Sometimes this is possible without an adjuvant, but frequently a pair of specially shaped forceps, known as Magill forceps, is required to guide the distal tip of the Nasal RAE into the glottis due to the curvature of these ETT. Magill forceps are introduced into the mouth and are used to grasp the distal end of the Nasal RAE and direct it into the glottis. Contrary to what the current literature suggests, it has been our experience that nasal intubations using the C-Mac frequently do not require the use of Magill forceps at nearly the same rate as DL. This technique may improve the time and ease to intubation because of not having to use the Magill forceps. The use of Magill forceps can be awkward for the clinician, with poor visualization due to obstruction of the view by this tool in the airway, and small working space within the posterior oropharynx. For these reasons, the possibility of not having to use Magill forceps because the investigators are using a C-Mac as the only tool to intubate is a potentially inviting one.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2016

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2016

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

January 12, 2017

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 26, 2017

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 7, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 7, 2017

Completed
11 months until next milestone

Results Posted

Study results publicly available

July 11, 2018

Completed
Last Updated

August 8, 2018

Status Verified

July 1, 2018

Enrollment Period

1.4 years

First QC Date

January 12, 2017

Results QC Date

June 14, 2018

Last Update Submit

July 10, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Participants Requiring Use of Magill Forceps for Nasal Intubations

    Reported as the number and percentage of participants that needed the use of Magill forceps during intubation

    1 day

Secondary Outcomes (4)

  • Time to Intubation

    1 day

  • Grade of Larynx View

    1 day

  • Presence of Nasal Bleeding

    1 day

  • Incidence of Failed Nasal Intubation

    1 day

Study Arms (2)

Direct Laryngoscopy

ACTIVE COMPARATOR

These patients will be nasally intubated for their procedure via direct laryngoscopy. We will observe and record incidence of Magill forcep use, presence or absence of nasal bleeding, and the grade of laryngeal view. We will also record any general narrative comments from the provider about the ease or difficulty of intubation.

Device: Direct Laryngoscopy

Video Laryngoscopy

EXPERIMENTAL

These patients will undergo Video Laryngoscopy for nasal intubation. We will observe and record incidence of Magill forcep use, presence or absence of nasal bleeding, and the grade of laryngeal view. We will also record any general narrative comments from the provider about the ease or difficulty of intubation.

Device: Video Laryngoscopy for nasal intubation

Interventions

The anesthesia provider will use a video laryngoscope to facilitate the nasal intubation for the procedure.

Video Laryngoscopy

These patients will be nasally intubated for their procedure via direct laryngoscopy

Direct Laryngoscopy

Eligibility Criteria

Age3 Years - 14 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Patients between the ages of 3 and 14 scheduled for comprehensive dental treatment under general anesthesia
  • Normal appearing airway upon pre-operative assessment

You may not qualify if:

  • Patient with a history of difficult airway/intubation
  • Patients suspected to have a difficult airway
  • History of cleft palate and/or cleft palate repair
  • Pregnancy
  • Emergency status of surgery
  • Any patient with a contra-indication to nasal tube placement
  • Any patient with a potentially increased risk of nasal bleeding from nasal placement of the ETT i.e. patients on aspirin or other anticoagulants, patient's with hemophilia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wake Forest University Health Sciences

Winston-Salem, North Carolina, 27157, United States

Location

Related Publications (3)

  • Sun Y, Lu Y, Huang Y, Jiang H. Pediatric video laryngoscope versus direct laryngoscope: a meta-analysis of randomized controlled trials. Paediatr Anaesth. 2014 Oct;24(10):1056-65. doi: 10.1111/pan.12458. Epub 2014 Jun 24.

    PMID: 24958249BACKGROUND
  • Kim HJ, Kim JT, Kim HS, Kim CS, Kim SD. A comparison of GlideScope((R)) videolaryngoscopy and direct laryngoscopy for nasotracheal intubation in children. Paediatr Anaesth. 2011 Apr;21(4):417-21. doi: 10.1111/j.1460-9592.2010.03517.x. Epub 2011 Jan 19.

  • Jones PM, Armstrong KP, Armstrong PM, Cherry RA, Harle CC, Hoogstra J, Turkstra TP. A comparison of glidescope videolaryngoscopy to direct laryngoscopy for nasotracheal intubation. Anesth Analg. 2008 Jul;107(1):144-8. doi: 10.1213/ane.0b013e31816d15c9.

Results Point of Contact

Title
Dr. Thomas Templeton
Organization
Wake Forest University Health Sciences

Study Officials

  • Thomas W Templeton, MD

    Wake Forest University Health Sciences

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 12, 2017

First Posted

January 26, 2017

Study Start

March 1, 2016

Primary Completion

August 7, 2017

Study Completion

August 7, 2017

Last Updated

August 8, 2018

Results First Posted

July 11, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share

Locations